SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bosco who wrote (807)3/20/2000 3:36:00 PM
From: Sten Frelles  Read Replies (1) of 1298
 
Thanks Bosco
Don't you think that CEGE trades in a peculiar pattern when compared with ABGX? Seems to me when ABGX takes a dip, CEGE overreacts - but when ABGX rises CEGE is slow to follow.

I've been checking into CEGE for the last month now, and have several positions above current levels (sigh). I just can't see why the rest of the world doesn't think this is "the buying opportunity of a lifetime" Is there something rotten at the botton of this Co. or is gene therapy just not promising enough yet to put a valuation on their IPR in that area.

Any thoughts?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News